World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
16345
World Ranking
19888
National Ranking
633

Masakazu Yashiro publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Masakazu Yashiro sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 541 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Masakazu Yashiro D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Masakazu Yashiro sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Masakazu Yashiro is affiliated with Osaka Metropolitan University in Japan and has contributed extensively to research in medicine, with a strong focus on biochemistry, genetics, and molecular biology. Their work spans multiple subfields including oncology, molecular biology, pulmonary and respiratory medicine, cancer research, and surgery.

Their research topics prominently feature gastric cancer management and outcomes, cancer cells and metastasis, cholangiocarcinoma and gallbladder cancer studies, pancreatic and hepatic oncology research, cancer immunotherapy and biomarkers, cancer hypoxia and metabolism, and cancer genomics and diagnostics.

Frequent co-authors in their publications include Yurie Yamamoto, Masaichi Ohira, Atsushi Sugimoto, Sadaaki Nishimura, and Tomohiro Sera.

Yashiro publishes often in notable venues such as Cancer Research, Anticancer Research, PLoS ONE, International Journal of Molecular Sciences, and Cancer Science.

Recent papers include:

  • Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors, 2020, Cancer Research
  • Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance, 2020, Cancer Research
  • Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population, 2020, Developmental Cell
  • The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment, 2022, Cancer Science
  • Novel biomarkers for early detection of gastric cancer, 2023, World Journal of Gastroenterology

Best Publications

  • Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

    Mitsunobu R. Kano;Younsoo Bae;Caname Iwata;Yasuyuki Morishita

  • Biomarkers of gastric cancer: Current topics and future perspective.

    Tasuku Matsuoka;Masakazu Yashiro

  • FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.

    Kaiko Kunii;Lenora Davis;Julie Gorenstein;Harold Hatch

  • Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

    Yoshitaka Hippo;Masakazu Yashiro;Masami Ishii;Hirokazu Taniguchi

  • Ulcerative colitis-associated colorectal cancer.

    Masakazu Yashiro

  • The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma

    Tasuku Matsuoka;Masakazu Yashiro

  • The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study

    Takahiro Toyokawa;Naoshi Kubo;Tatsuro Tamura;Katsunobu Sakurai

  • Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells

    Takatsugu Ishimoto;Takatsugu Ishimoto;Keisuke Miyake;Tannistha Nandi;Masakazu Yashiro

  • Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.

    Motohiko Tokuhisa;Yasushi Ichikawa;Nobuyoshi Kosaka;Takahiro Ochiya

  • Genetic pathways in the evolution of morphologically distinct colorectal neoplasms.

    M Yashiro;J M Carethers;L Laghi;K Saito

  • Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma

    Junko Matsuoka;Masakazu Yashiro;Katsunobu Sakurai;Naoshi Kubo

  • Prognostic Value of Microsatellite Instability in Resectable Pancreatic Cancer

    Bunzo Nakata;Yan Qing Wang;Masakazu Yashiro;Nobuaki Nishioka

  • Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via Reduction of Lymphangiogenesis

    Caname Iwata;Mitsunobu R. Kano;Akiyoshi Komuro;Masako Oka

  • Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.

    Yu Kataoka;Toru Mukohara;Hideo Tomioka;Yohei Funakoshi

  • HER2 overexpression correlates with survival after curative resection of pancreatic cancer

    Masahiro Komoto;Bunzo Nakata;Ryosuke Amano;Nobuya Yamada

  • Predictive Potential of Preoperative Nutritional Status in Long-Term Outcome Projections for Patients with Gastric Cancer

    Katsunobu Sakurai;Masaichi Ohira;Tatsuro Tamura;Takahiro Toyokawa

  • Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice

    Masakazu Yashiro;Yong-Suk Chung;Shigehiko Nishimura;Tohru Inoue

  • Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.

    Hiroshi Sootome;Hidenori Fujita;Kenjiro Ito;Hiroaki Ochiiwa

  • Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection

    Kotaro Kiga;Hitomi Mimuro;Masato Suzuki;Aya Shinozaki-Ushiku

  • Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts

    Wei-meng Zhao;Lihong Wang;Hangil Park;Sophea Chhim

Frequent Co-Authors

Kosei Hirakawa
Kosei Hirakawa Osaka Metropolitan University
Kohei Miyazono
Kohei Miyazono University of Tokyo
Wataru Yasui
Wataru Yasui Hiroshima University
Hideo Baba
Hideo Baba Kumamoto University
Hideki Yamaguchi
Hideki Yamaguchi Sasaki Institute
Yasuyuki Morishita
Yasuyuki Morishita University of Tokyo
Patrick Tan
Patrick Tan Duke NUS Graduate Medical School
Hiroyuki Aburatani
Hiroyuki Aburatani University of Tokyo
Kenneth Olden
Kenneth Olden National Institutes of Health
Toshikazu Ushijima
Toshikazu Ushijima National Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, several online degrees and pathways can complement your journey or offer alternative roles in healthcare. For those interested in healthcare leadership, a health care administration degree provides skills in managing clinics, hospitals, and health organizations, ideal for professionals aiming to shape the future of healthcare systems.

Current registered nurses who wish to advance their scope of practice can look into rn to np bridge programs. These programs allow RNs to earn a master's degree efficiently and become nurse practitioners, expanding both career and salary opportunities.

For those passionate about the science of nutrition and health promotion, pursuing a nutrition bachelor degree online is a flexible option. This path can lead to roles in public health, wellness coaching, or further studies in dietetics.

Aspiring healthcare executives can consider accredited online mha programs, which emphasize strategic management, healthcare policy, and leadership in the industry. All these options represent important avenues for those seeking impactful careers alongside—or beyond—traditional medical practice.

Best Scientists Citing Masakazu Yashiro

Trending Scientists

Recently Published Articles